Doughman’s collaborations with senior medical and scientific experts in India helped define trends in onset correlated with urbanization and modern dietary changes. He pointed out the greatest incidence of type-2-diabetes occurs in India, China and the USA, respectively (1).
Their report does not discuss relative rates of onset in these countries other than the fact that world diabetes onset is doubling every 30 years, with 200 million people worldwide diagnosed to have this largely preventable disease.
Doughman commented on the quality and safety of algae oil and the global diabetes need. “Based on a full survey of the evidence-based literature, there is a tremendous opportunity for more omega-3 research from university groups. We report how algae oil significantly and safely benefits diabetics with dyslipidemias and elevated postprandial triglycerides, without introducing any known glucose control side effects or drug interactions in this population,” he said.
Lead editor of the book compilation, Dr. Gottipolu R. Reddy, is Professor and Head, Division of Neuroscience, Department of Zoology, Sri Venkateswara University, Tirupati, India. Dr. Reddy is known internationally for his research in the area of developmental neurotoxicity of heavy metals. Dr. Reddy and Dr. Doughman met at a 2009 symposia at the historic Bangalore University, Department of Zoology, where each had been invited speakers.
High-DHA algae oil has no environmental pollutants, is natural cultured oil grown in enclosed controlled systems. The safety of high-DHA omega-3 algae oil intake by a type-2-diabetic was previously published on in review by Doughman et al., 2007 (2).
Other Source-Omega publications and articles in India on algae oil topics include peer reviewed manuscripts published in 2008 with the Indian Science Congress and in 2009 by the University of Madras, Department of Zoology. Recently Doughman’s Visiting Faculty work has been written about by the Asian Scientist (3,4,5).
The company suggested that future studies on environmental pollution-effects will likely show significant contributions to diabetes onset worldwide, but acknowledged that algae oil DHA can only address the chronic dietary component of the disease.
Doughman commented, “Progress is being made in educating about the two sides of the type-2-diabetes coin, sugar and fat, not just sugar.”
He then added, “We should not say the cause is the ‘Western diet’. Diabetes is increasing with convenience diets, affluence, urbanization and possibly pollution. To say Western diet invites cultural blame and most diabetics do not eat a Western diet, rather refined sugars, starches and oils all play contributing roles as added ingredients in processed foods made all around the world.”
Current science and consensus indicates eating fish is linked to lower blood glucose concentrations and the related associations to a reduced risk of developing diabetes, discovered as a result of the Prevention with a Mediterranean Diet study conducted by Mercedes Sotos Prieto in Spain through the University of Valencia. The study was conducted with the Valencia population involving 945 people (340 men and 605 women) between the ages of 55 to 80 who had high cardiovascular risk backgrounds.
Source-Omega is a member of the Global Organization for EPA and DHA Omega-3s (GOED), a trade group advocating for the ethical and sustainable use of omega-3 fatty acids in nutrition and medicine. GOED’s website [http://www.goedomega3.com] suggests omega-3 prevention measures worldwide could help save $47 trillion in chronic disease costs, including the long term complications and costs associated with the diabetes epidemic.
(1) Doughman. A Substitute for Fish Oil: Qualifying Algae Oil Omega-3s as a Medical Food. (2011), in press, reprints available upon request.
(2) Doughman et al., Omega-3 fatty acids for nutrition and medicine: considering microalgae oil as a vegetarian source of EPA and DHA. Curr Diabetes Rev. (2007), 3:198-203
P.O. Box 5208
Chapel Hill, NC 27516